AdnaTest BreastCancerSelect

Enrichment of tumor cells from blood of breast cancer patients for gene expression analysis

AdnaTest BreastCancerSelect is for in vitro diagnostic use only and was developed for the enrichment of circulating tumor cells from peripheral blood of breast cancer patients.

For detailed information about CTC diagnostics, please visit this link.

In the first step cancer cells will be enriched in vitro from cancer patients` blood samples (EDTA or AdnaCollect) using magnetic bead conjugated antibodies. The antibody cocktail was carefully optimized for the cancer type.

For a more detailed product description, download the
  AdnaTest BreastCancerSelect manual

The AdnaTest ColonCancer and AdnaTest BreastCancer products are CE-certified for the detection of circulating tumor cells.

AdnaTest BreastCancerDetect is recommended for the subsequent analysis of the breast cancer associated gene expression.

AdnaCollect tubes can be used for blood withdrawal.